Takeda Pharmaceutical Co Ltd
TSE:4502
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
N
|
Nestle SA
XMUN:NESR
|
CH |
|
J
|
J B Hunt Transport Services Inc
XMUN:JB1
|
US |
|
C
|
Caterpillar Inc
SGO:CAT
|
US |
|
N
|
New Talisman Gold Mines Ltd
ASX:NTL
|
NZ |
|
A
|
American Express Co
F:AEC1
|
US |
|
Isuzu Motors Ltd
TSE:7202
|
JP |
|
Siltronic AG
OTC:SLTCY
|
DE |
|
Isuzu Motors Ltd
OTC:ISUZF
|
JP |
|
Alphamin Resources Corp
XTSX:AFM
|
MU |
|
S
|
SSR Mining Inc
TSX:SSRM
|
CA |
|
Gecina SA
LSE:0OPE
|
FR |
|
H
|
HUYA Inc
F:HY5A
|
CN |
|
C
|
China Pacific Insurance Group Co Ltd
F:75CB
|
CN |
|
W
|
World Acceptance Corp
SWB:WOA
|
US |
|
DaVita Inc
NYSE:DVA
|
US |
Wall St Price Targets
Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 6 375.24 JPY with a low forecast of 5 252 JPY and a high forecast of 8 295 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Takeda Pharmaceutical Co Ltd's stock price target?
Price Target
6 375.24
JPY
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 6 375.24 JPY with a low forecast of 5 252 JPY and a high forecast of 8 295 JPY.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Pre-Tax Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
43%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 43%.
